Thomas R. E. Barnes

24.8k total citations · 4 hit papers
256 papers, 16.3k citations indexed

About

Thomas R. E. Barnes is a scholar working on Psychiatry and Mental health, Philosophy and Clinical Psychology. According to data from OpenAlex, Thomas R. E. Barnes has authored 256 papers receiving a total of 16.3k indexed citations (citations by other indexed papers that have themselves been cited), including 198 papers in Psychiatry and Mental health, 50 papers in Philosophy and 43 papers in Clinical Psychology. Recurrent topics in Thomas R. E. Barnes's work include Schizophrenia research and treatment (182 papers), Mental Health and Psychiatry (50 papers) and Bipolar Disorder and Treatment (48 papers). Thomas R. E. Barnes is often cited by papers focused on Schizophrenia research and treatment (182 papers), Mental Health and Psychiatry (50 papers) and Bipolar Disorder and Treatment (48 papers). Thomas R. E. Barnes collaborates with scholars based in United Kingdom, United States and Australia. Thomas R. E. Barnes's co-authors include Peter B. Jones, Eileen M. Joyce, Christos Pantelis, Carol Paton, Glyn Lewis, Anne Lingford‐Hughes, Margaret Burke, Stanley Zammit, Theresa HM Moore and Shôn Lewis and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and NeuroImage.

In The Last Decade

Thomas R. E. Barnes

254 papers receiving 15.5k citations

Hit Papers

A Rating Scale for Drug-I... 1989 2026 2001 2013 1989 2007 2006 2021 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Rating Scale for Drug-Induced Akathisia
    1989 1.9k citations Thomas R. E. Barnes The British Journal of Psychiatry profile →
  2. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
    2007 1.6k citations Thomas R. E. Barnes, Peter B. Jones et al. profile →
  3. Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia
    2006 755 citations Peter B. Jones, Thomas R. E. Barnes et al. profile →
  4. The Maudsley Prescribing Guidelines in Psychiatry
    2021 327 citations David Taylor, Thomas R. E. Barnes et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Thomas R. E. Barnes 11.4k 3.5k 2.9k 2.7k 2.7k 256 16.3k
Joseph P. McEvoy 15.5k 1.4× 4.1k 1.2× 2.1k 0.7× 1.6k 0.6× 3.5k 1.3× 227 20.6k
Hans‐Jürgen Möller 9.5k 0.8× 3.1k 0.9× 3.8k 1.3× 2.9k 1.1× 1.5k 0.6× 323 17.1k
T. Scott Stroup 13.6k 1.2× 3.5k 1.0× 1.8k 0.6× 1.1k 0.4× 2.9k 1.1× 185 18.8k
Mauricio Tohen 17.1k 1.5× 4.0k 1.1× 3.3k 1.2× 1.9k 0.7× 1.7k 0.6× 374 20.6k
Sonia M. Davis 9.4k 0.8× 2.2k 0.6× 2.0k 0.7× 1.1k 0.4× 1.7k 0.6× 103 15.2k
Gary Remington 11.3k 1.0× 2.6k 0.7× 1.9k 0.7× 3.1k 1.1× 2.4k 0.9× 468 17.8k
Rolf R. Engel 8.8k 0.8× 2.8k 0.8× 1.9k 0.7× 2.2k 0.8× 1.6k 0.6× 230 14.4k
Barry D. Lebowitz 9.7k 0.9× 3.7k 1.0× 6.2k 2.2× 2.4k 0.9× 1.2k 0.4× 149 20.2k
Henry A. Nasrallah 9.1k 0.8× 2.3k 0.6× 1.0k 0.4× 2.6k 1.0× 1.6k 0.6× 351 15.2k
Werner Kissling 9.8k 0.9× 3.4k 1.0× 2.0k 0.7× 820 0.3× 2.8k 1.1× 205 14.1k

Countries citing papers authored by Thomas R. E. Barnes

Since Specialization
Citations

This map shows the geographic impact of Thomas R. E. Barnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas R. E. Barnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas R. E. Barnes more than expected).

Fields of papers citing papers by Thomas R. E. Barnes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas R. E. Barnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas R. E. Barnes. The network helps show where Thomas R. E. Barnes may publish in the future.

Co-authorship network of co-authors of Thomas R. E. Barnes

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas R. E. Barnes. A scholar is included among the top collaborators of Thomas R. E. Barnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas R. E. Barnes. Thomas R. E. Barnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moncrieff, Joanna, Eva K. Pillai, Louise Marston, et al.. (2025). The association between relapse and the outcome of schizophrenia and recurrent psychotic disorders. The British Journal of Psychiatry. 227(4). 673–679.
2.
Barnes, Thomas R. E., et al.. (2024). Understanding the medication regimens associated with anticholinergic burden in older people's mental health services in the UK. BJPsych Open. 10(5). e167–e167. 1 indexed citations
3.
Paton, Carol, et al.. (2024). Exploring the clinical factors affecting lithium dose and plasma level and the effect of brand. SHILAP Revista de lepidopterología. 14. 1957203195–1957203195.
4.
Paton, Carol, et al.. (2024). Quality of melatonin use in children and adolescents: findings from a UK clinical audit. SHILAP Revista de lepidopterología. 27(1). e300894–e300894. 1 indexed citations
5.
Barnes, Thomas R. E., et al.. (2022). Prescribing clozapine in the UK: Quality improvement issues identified by clinical audit. Journal of Psychopharmacology. 36(9). 1036–1040. 3 indexed citations
6.
Cousins, David A., et al.. (2022). Plus ça change? Switching lithium preparations. BJPsych Bulletin. 47(2). 71–76. 1 indexed citations
7.
Howes, Oliver, Thomas R. E. Barnes, Belinda Lennox, Sarah Markham, & Sridhar Natesan. (2022). Time to re-evaluate the risks and benefits of valproate and a call for action. The British Journal of Psychiatry. 221(6). 711–713. 1 indexed citations
8.
Paton, Carol, et al.. (2022). Who is prescribed valproate and how carefully is this treatment reviewed in UK mental health services? Data from a clinical audit. SHILAP Revista de lepidopterología. 12. 2 indexed citations
9.
Watson, Andrew, Annalisa Giordano, John Suckling, et al.. (2022). Cognitive function in early-phase schizophrenia-spectrum disorder: IQ subtypes, brain volume and immune markers. Psychological Medicine. 53(7). 2842–2851. 9 indexed citations
10.
Crawford, Mike, Verity C. Leeson, Rachel Evans, et al.. (2022). The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trial. SHILAP Revista de lepidopterología. 12. 1937008144–1937008144. 5 indexed citations
11.
Paton, Carol, et al.. (2021). Side-effect monitoring of continuing LAI antipsychotic medication in UK adult mental health services. SHILAP Revista de lepidopterología. 11. 3629556846–3629556846. 2 indexed citations
12.
13.
Paton, Carol, et al.. (2020). Prescribing for moderate or severe unipolar depression in patients under the long-term care of UK adult mental health services. SHILAP Revista de lepidopterología. 10. 3628496060–3628496060. 6 indexed citations
14.
Crawford, Mike, Lavanya Thana, Rachel Evans, et al.. (2020). Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT. Health Technology Assessment. 24(44). 1–54. 8 indexed citations
15.
Barnes, Thomas R. E., et al.. (2020). The physical health and side-effect monitoring of patients prescribed clozapine: data from a clinical audit conducted in UK mental health services. SHILAP Revista de lepidopterología. 10. 3628503476–3628503476. 9 indexed citations
16.
Deakin, J.F.W., John Suckling, Paola Dazzan, et al.. (2019). Minocycline for negative symptoms of schizophrenia and possible mechanistic actions: the BeneMin RCT. SHILAP Revista de lepidopterología. 6(7). 1–66. 7 indexed citations
17.
Tibber, Marc S., James B. Kirkbride, Eileen M. Joyce, et al.. (2018). The component structure of the scales for the assessment of positive and negative symptoms in first-episode psychosis and its dependence on variations in analytic methods. Psychiatry Research. 270. 869–879. 17 indexed citations
18.
Krynicki, Carl R., Rachel Upthegrove, J.F.W. Deakin, & Thomas R. E. Barnes. (2018). The relationship between negative symptoms and depression in schizophrenia: a systematic review. Acta Psychiatrica Scandinavica. 137(5). 380–390. 149 indexed citations
19.
20.
Barnes, Thomas R. E. & Eileen M. Joyce. (2001). Antipsychotic drug treatment: recent advances. Current Opinion in Psychiatry. 14(1). 25–37. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph P. McEvoy Breakdown of academic impact, for papers by Hans‐Jürgen Möller Breakdown of academic impact, for papers by T. Scott Stroup Breakdown of academic impact, for papers by Mauricio Tohen Breakdown of academic impact, for papers by Sonia M. Davis Breakdown of academic impact, for papers by Gary Remington Breakdown of academic impact, for papers by Rolf R. Engel Breakdown of academic impact, for papers by Barry D. Lebowitz Breakdown of academic impact, for papers by Henry A. Nasrallah Breakdown of academic impact, for papers by Werner Kissling
Rankless by CCL
2026